$50B market cap ÷ 10 = $5B turnover. This is easy to achieve giving just one more FDA approval out of the plethora expected, and is not even taking into account the further pipeline of products. And cancer therapeutics is the gamechanger which can achieve this shareprice as a standalone product!
Understanding Telix, page-725
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.46 |
Change
-0.200(1.20%) |
Mkt cap ! $5.499B | |||
| Open | High | Low | Value | Volume |
| $16.73 | $16.78 | $16.42 | $17.90M | 1.081M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 12554 | $16.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.50 | 8212 | 3 |
View Market Depth
| Last trade - 16.10pm 12/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$16.54 |
Change
-0.200 ( 0.56 %) |
||||
| Open | High | Low | Volume | ||
| $16.71 | $16.78 | $16.43 | 186068 | ||
| Last updated 15.59pm 12/06/2024 ? | |||||
| TLX (ASX) Chart |